A MISC 05451 Academy of Next Wave Investigators banner scaled
Opening: April 1, 2022
Due date: May 9, 2022
Notification: June 1, 2022
Selected young investigators will be provided:
  • Registration at exclusive 1 ½ day conference featuring sessions with leading faculty on CLL and NHL, professional development, and networking opportunities.
  •  Travel to attend the conference and two nights accommodation at the venue hotel.
  •  Matching with a mentor for regular touchpoints during the year in their specialty.
  •  Quarterly virtual meetings on professional development topics.
  •  Reception to be held at the American Society of Hematology 2022 Annual Meeting.
Top five abstract submissions will additionally receive:
  • An opportunity to present a five-minute oral presentation during the conference recognition as a top performer in the Academy
One additional applicant will be recognized for having the top presentation skills.
The top 25 applicants will be invited to participate in the Next Wave Academy.
  • Applicants must be in their final two years of a fellowship program or within five years post-fellowship
  • Applicants must be US-based and currently employed in active patient care or lab-based research in CLL or NHL or being trained at, an institution in the United States. Applicants must not be employed by a commercial pharmaceutical or other biomedical company.
  • Applicants must hold a MD, PhD, DO or MBBS degree.
  • Selected applicants must commit to actively participating in the program for the full year of activities.
  • Individuals residing or working outside of the US at the time of application are not eligible.
  • Individuals who have received independent research funding at the time of application.
Applicants must complete the online application including the materials below:
  • Recommendation letter from fellowship director or thought leader in the field of CLL or NHL
  • CV (maximum five pages)
  • Two minute video explaining why they want to participate in the Next Wave Academy, demonstrating the applicants presentation skills and detailing their goals for the one-year mentoring program
  • Submission of an abstract for the conference
Selection process:
The Steering Committee will review all applications. Applicants will be evaluated on the following criteria:
  • Contribution to science: Clear commitment to an academic oncology career through publication and project efforts, and training to date.
  • Clear goals: Specific and achievable aims for the mentoring program.
  • Abstract quality: Quality of the submitted abstract.
Participant responsibilities:
If selected to participate in the Next Wave Academy, participants are obligated to:
  • Actively participate in the Next Wave Academy conference (DATES), mentorship program and quarterly professional development events
  • Present their submitted abstract during the Next Wave Academy conference
  • Participate in program evaluation